Biocon informs about press release

17 Oct 2022 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

379.70 10.60 (2.87%)
25-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.85
Dr. Reddys Lab 1301.90
Cipla 1243.90
Zydus Lifesciences 903.60
Lupin 2347.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×